SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001169232-08-001274
Filing Date
2008-03-10
Accepted
2008-03-07 17:41:17
Documents
10
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 form10k.htm 10-K 1880971
2 GRAPHIC ballotx.jpg GRAPHIC 762
3 ex3-2.htm EX-3.(I) 126336
4 ex311.htm EX-31 13703
5 ex312.htm EX-31 13604
6 ex321.htm EX-32 4390
7 ex322.htm EX-32 4570
8 ex106.htm EX-10 19106
9 LIST OF SUBSIDIARIES d73838_ex21-1.htm EX-21.1 10889
10 EX 23.1 ex23.htm EX-23 2140
  Complete submission text file 0001169232-08-001274.txt   2078308
Mailing Address 2273 RESEARCH BLVD, SUITE 400 ROCKVILLE MD 20850
Business Address 2273 RESEARCH BLVD, SUITE 400 ROCKVILLE MD 20850 (301) 795-1800
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

IRS No.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33137 | Film No.: 08675343
SIC: 2834 Pharmaceutical Preparations